A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Clinical trial NCT05556343 · TERMINATED
Trial details
- NCT number
- NCT05556343
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-18
- Primary completion
- 2024-08-19
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.